Silverback Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$7.55-$18.51
Market Cap
$1.1B
Shares Short
14M

Financials

See more
Revenue (12 Mos)
$2.5M
Revenue Growth (YoY)
4,900%
Gross Profit (12 Mos)
-$17.3M
Diluted EPS
-$0.50

News

See more

Yahoo Finance • last year

ARS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Updates

Yahoo Finance • last year

ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxis

Yahoo Finance • last year

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Investigate ARS Pharmaceuticals, Inc. (SPRY) for Potential Violations of Securities Laws

Yahoo Finance • last year

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of ARS Pharmaceuticals, Inc.(SPRY)

About

CEO
Mr. Richard Lowenthal M.B.A., M.S., MSMSEL
Address
11682 El Camino Real, San Diego, CA, United States, 92130
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
23